ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,686Medicare Part D Prescriptions Filled, Including Refills

Rank: 1131 out of 5176

$494K Total Retail Price of All Prescriptions

Rank: 1206 out of 5176

294 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 294 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 294 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 7,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 289 261 1 1
AMLODIPINE BESYLATE 249 229 2 2
DONEPEZIL HCL 224 224 3 28
OMEPRAZOLE 224 222 3 3
METOPROLOL TARTRATE 215 212 5 6
NAMENDA 213 213 6 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 194 180 7 49
FUROSEMIDE 175 173 8 8
CITALOPRAM HBR 156 156 9 31
LEVOTHYROXINE SODIUM 153 149 10 4
POTASSIUM CHLORIDE 150 147 11 34
ZOLPIDEM TARTRATE 148 124 12 17
METOPROLOL SUCCINATE 139 136 13 11
LISINOPRIL 130 122 14 5
ATORVASTATIN CALCIUM 126 123 15 9
WARFARIN SODIUM 116 116 16 13
GABAPENTIN 109 95 17 21
HYDROCHLOROTHIAZIDE 102 98 18 10
LOSARTAN POTASSIUM 95 95 19 14
TAMSULOSIN HCL 92 78 20 20
CIPROFLOXACIN HCL 85 77 21 84
CARVEDILOL 84 77 22 24
SERTRALINE HCL 76 59 23 30
LEVETIRACETAM 74 66 24 92
PREDNISONE 71 60 25 52
ISOSORBIDE MONONITRATE ER 69 69 26 44
SSD 68 68 27 216
ENALAPRIL MALEATE 67 67 28 22
ALBUTEROL SULFATE 67 67 28 99
DIGOXIN 67 60 28 56
LACTULOSE 67 67 28 87
AZITHROMYCIN 65 59 32 42
ADVAIR DISKUS 64 60 33 32
CLOPIDOGREL 62 53 34 26
SPIRIVA 62 62 34 54
RANITIDINE HCL 58 53 36 36
METFORMIN HCL 57 46 37 7
LOSARTAN-HYDROCHLOROTHIAZIDE 56 52 38 35
ATENOLOL 54 53 39 12
NEXIUM 53 48 40 16
JANUVIA 53 42 40 25
LOVASTATIN 52 52 42 46
METFORMIN HCL ER 50 41 43 57
CYMBALTA 50 32 43 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.